Yang Z, Shi G, et al. - Researchers aimed at comparing combined hepatocellular-cholangiocarcinoma (CHC) and intrahepatic cholangiocarcinoma (ICC) and investigating the treatment and survival of patients with CHC.

• From the SEER database, researchers retrieved data of a total of 1,066 consecutive patients who had been diagnosed with CHC (n = 286) or ICC (n = 780).

• Better long-term survival outcomes were achieved in patients with CHC in correlation with receiving surgical intervention vs nonsurgical treatments.

• The OS rate of CHC patients vs ICC patients was comparable in the initial 36 months and better in the subsequent follow-up after treatment.